Literature DB >> 15863782

The case for practical clinical trials in psychiatry.

John S March1, Susan G Silva, Scott Compton, Mark Shapiro, Robert Califf, Ranga Krishnan.   

Abstract

OBJECTIVE: Clinical trials in psychiatry frequently fail to maximize clinical utility for practicing clinicians, or, stated differently, available evidence is not perceived by clinicians (and other decision makers) as sufficiently relevant to clinical practice, thereby diluting its impact. To attain maximum clinical relevance and acceptability, researchers must conduct clinical trials designed to meet the needs of clinicians and others who are making decisions about patients' care. The authors present the case for psychiatry's adoption of the practical clinical trials model, which is widely used in research in other areas of medicine.
METHOD: The authors outline the characteristics and scope of practical clinical trials, give examples of practical clinical trials, and discuss the challenges of using the practical clinical trials model in psychiatry, including issues of funding.
RESULTS: Practical clinical trials, which are intended to provide generalizable answers to important clinical questions without bias, are characterized by eight key features: a straightforward clinically relevant question, a representative sample of patients and practice settings, sufficient power to identify modest clinically relevant effects, randomization to protect against bias, clinical uncertainty regarding the outcome of treatment at the patient level, assessment and treatment protocols that enact best clinical practices, simple and clinically relevant outcomes, and limited subject and investigator burden.
CONCLUSIONS: To implement the practical clinical trials model in psychiatry will require stable funding for network construction and maintenance plus methodological innovation in governance and trial selection, assessment, treatment, data management, site management, and data analytic procedures.

Entities:  

Mesh:

Year:  2005        PMID: 15863782     DOI: 10.1176/appi.ajp.162.5.836

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  57 in total

1.  Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact.

Authors:  Geoffrey M Curran; Mark Bauer; Brian Mittman; Jeffrey M Pyne; Cheryl Stetler
Journal:  Med Care       Date:  2012-03       Impact factor: 2.983

2.  What have we learned about trial design from NIMH-funded pragmatic trials?

Authors:  John March; Helena C Kraemer; Madhukar Trivedi; John Csernansky; John Davis; Terence A Ketter; Ira D Glick
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

3.  Beyond efficacy: the STAR*D trial.

Authors:  Thomas R Insel
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

4.  New developments in the treatment of attention-deficit/hyperactivity disorder in primary care.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

Review 5.  Issues in selecting outcome measures to assess functional recovery after stroke.

Authors:  Sharon Barak; Pamela W Duncan
Journal:  NeuroRx       Date:  2006-10

6.  Bringing a research base to psychiatry.

Authors:  Miriam Shuchman; Paul C Hébert; Rajendra Kale; Barbara Sibbald; Ken Flegel; Noni MacDonald
Journal:  CMAJ       Date:  2008-05-06       Impact factor: 8.262

7.  Enhanced fidelity to treatment for bipolar disorder: results from a randomized controlled implementation trial.

Authors:  Jeanette Waxmonsky; Amy M Kilbourne; David E Goodrich; Kristina M Nord; Zongshan Lai; Christina Laird; Julia Clogston; Hyungjin Myra Kim; Christopher Miller; Mark S Bauer
Journal:  Psychiatr Serv       Date:  2014-01-01       Impact factor: 3.084

8.  Long-term (3-year) effectiveness of haloperidol, risperidone and olanzapine: results of a randomized, flexible-dose, open-label comparison in first-episode nonaffective psychosis.

Authors:  Benedicto Crespo-Facorro; Rocío Pérez-Iglesias; Ignacio Mata; Obdulia Martínez-Garcia; Victor Ortiz; Jose Maria Pelayo-Terán; Elsa Valdizan; José Luis Vazquez-Barquero
Journal:  Psychopharmacology (Berl)       Date:  2011-07-07       Impact factor: 4.530

9.  Randomized effectiveness trial of an Internet, pure self-help, cognitive behavioral intervention for depressive symptoms in young adults.

Authors:  Greg Clarke; Chris Kelleher; Matt Hornbrook; Lynn Debar; John Dickerson; Christina Gullion
Journal:  Cogn Behav Ther       Date:  2009

10.  The child and adolescent psychiatry trials network (CAPTN): infrastructure development and lessons learned.

Authors:  Mark Shapiro; Susan G Silva; Scott Compton; Allan Chrisman; Joseph DeVeaugh-Geiss; Alfiee Breland-Noble; Douglas Kondo; Jerry Kirchner; John S March
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2009-03-25       Impact factor: 3.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.